DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 5 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,684,415 | +14.3% | 114,043 | 0.0% | 0.04% | +20.6% |
| Q2 2023 | $1,473,436 | +31.7% | 114,043 | 0.0% | 0.03% | +3.0% |
| Q1 2023 | $1,118,762 | -7.8% | 114,043 | 0.0% | 0.03% | -2.9% |
| Q4 2022 | $1,213,418 | +1.9% | 114,043 | -0.0% | 0.03% | -2.9% |
| Q3 2022 | $1,191,000 | -55.3% | 114,058 | +0.2% | 0.04% | -27.1% |
| Q2 2015 | $2,667,000 | +3.6% | 113,856 | -0.8% | 0.05% | +6.7% |
| Q1 2015 | $2,575,000 | +32.9% | 114,803 | -0.1% | 0.04% | +25.0% |
| Q4 2014 | $1,938,000 | – | 114,949 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |